Tapewire

NYSE · USD

TDOC

Teladoc Health, Inc.

Export transactions ↓
Tapewire entity
1547
SEC CIK
0001477449
Parsed reports
839

Last 12 months

Inside the activity.

1 purchase rows · 37 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202510
Dec 202506
Jan 202601
Feb 202600
Mar 202608
Apr 202601
May 202600
Jun 202609
Jul 202603
Aug 202600
Sep 202608
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
October 05, 2020 Filed Oct 6, 2020 16:11 UTC
Turitz AndrewSVP - Business Development
Exercise / conversionCommon Stock 1,389 $22.30 $30,974.70
Disclosure

SEC source: 0001179110-20-010308 · edgar.xml · nonDerivative · entry 3

Turitz Andrew · CIK 0001726221 · SVP - Business Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,404

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 05, 2020 Filed Oct 6, 2020 20:12 UTC
Vandervoort Adam CChief Legal Officer, Secretary
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 1,164 $0.00 Strike: $38.55 $0.00
Disclosure

SEC source: 0001179110-20-010309 · edgar.xml · derivative · entry 5

Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,798

Underlying: Common Stock · 1,164 shares

Expires 2028-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option vested as to 25% of the shares on March 1, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter.

Read SEC document
October 05, 2020 Filed Oct 6, 2020 20:12 UTC
Vandervoort Adam CChief Legal Officer, Secretary
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 1,446 $0.00 Strike: $22.30 $0.00
Disclosure

SEC source: 0001179110-20-010309 · edgar.xml · derivative · entry 4

Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,234

Underlying: Common Stock · 1,446 shares

Expires 2027-03-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vested as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter.

Read SEC document
October 05, 2020 Filed Oct 6, 2020 20:12 UTC
Vandervoort Adam CChief Legal Officer, Secretary
SaleCommon Stock 2,610 $222.46 $580,620.60
Disclosure

SEC source: 0001179110-20-010309 · edgar.xml · nonDerivative · entry 3

Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 16, 2020.

Read SEC document
October 05, 2020 Filed Oct 6, 2020 20:12 UTC
Vandervoort Adam CChief Legal Officer, Secretary
Exercise / conversionCommon Stock 1,164 $38.55 $44,872.20
Disclosure

SEC source: 0001179110-20-010309 · edgar.xml · nonDerivative · entry 2

Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,810

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 05, 2020 Filed Oct 6, 2020 20:12 UTC
Vandervoort Adam CChief Legal Officer, Secretary
Exercise / conversionCommon Stock 1,446 $22.30 $32,245.80
Disclosure

SEC source: 0001179110-20-010309 · edgar.xml · nonDerivative · entry 1

Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,646

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 02, 2020 Filed Oct 6, 2020 16:11 UTC
Turitz AndrewSVP - Business Development
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 717 $0.00 Strike: $38.55 $0.00
Disclosure

SEC source: 0001179110-20-010308 · edgar.xml · derivative · entry 5

Turitz Andrew · CIK 0001726221 · SVP - Business Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,183

Underlying: Common Stock · 717 shares

Expires 2028-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vested as to 25% of the shares on March 1, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter.

Read SEC document
October 02, 2020 Filed Oct 6, 2020 16:11 UTC
Turitz AndrewSVP - Business Development
SaleCommon Stock 717 $225.00 $161,325.00
Disclosure

SEC source: 0001179110-20-010308 · edgar.xml · nonDerivative · entry 2

Turitz Andrew · CIK 0001726221 · SVP - Business Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,015

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 3, 2020.

Read SEC document
October 02, 2020 Filed Oct 6, 2020 16:11 UTC
Turitz AndrewSVP - Business Development
Exercise / conversionCommon Stock 717 $38.55 $27,640.35
Disclosure

SEC source: 0001179110-20-010308 · edgar.xml · nonDerivative · entry 1

Turitz Andrew · CIK 0001726221 · SVP - Business Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,732

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 01, 2020 Filed Oct 5, 2020 16:02 UTC
Verstraete StephanyChief Marketing Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 6,000 $0.00 Strike: $22.30 $0.00
Disclosure

SEC source: 0001179110-20-010217 · edgar.xml · derivative · entry 3

Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,600

Underlying: Common Stock · 6,000 shares

Expires 2027-03-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vested as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter.

Read SEC document
October 01, 2020 Filed Oct 5, 2020 16:02 UTC
Verstraete StephanyChief Marketing Officer
SaleCommon Stock 6,000 $222.86 $1,337,160.00
Disclosure

SEC source: 0001179110-20-010217 · edgar.xml · nonDerivative · entry 2

Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,276

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 4, 2020.

Read SEC document
October 01, 2020 Filed Oct 5, 2020 16:02 UTC
Verstraete StephanyChief Marketing Officer
Exercise / conversionCommon Stock 6,000 $22.30 $133,800.00
Disclosure

SEC source: 0001179110-20-010217 · edgar.xml · nonDerivative · entry 1

Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,276

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 01, 2020 Filed Oct 5, 2020 20:02 UTC
Levy LewisChief Medical Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 1,275 $0.00 Strike: $38.55 $0.00
Disclosure

SEC source: 0001179110-20-010218 · edgar.xml · derivative · entry 5

Levy Lewis · CIK 0001726568 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,439

Underlying: Common Stock · 1,275 shares

Expires 2028-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option vests as to 25% of the shares on March 1, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter.

Read SEC document
October 01, 2020 Filed Oct 5, 2020 20:02 UTC
Levy LewisChief Medical Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 1,395 $0.00 Strike: $35.45 $0.00
Disclosure

SEC source: 0001179110-20-010218 · edgar.xml · derivative · entry 4

Levy Lewis · CIK 0001726568 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,463

Underlying: Common Stock · 1,395 shares

Expires 2027-07-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vests as to 25% of the shares on July 14, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter.

Read SEC document
October 01, 2020 Filed Oct 5, 2020 20:02 UTC
Levy LewisChief Medical Officer
SaleCommon Stock 2,670 $222.86 $595,036.20
Disclosure

SEC source: 0001179110-20-010218 · edgar.xml · nonDerivative · entry 3

Levy Lewis · CIK 0001726568 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,766

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 13, 2020.

Read SEC document
October 01, 2020 Filed Oct 5, 2020 20:02 UTC
Levy LewisChief Medical Officer
Exercise / conversionCommon Stock 1,275 $38.55 $49,151.25
Disclosure

SEC source: 0001179110-20-010218 · edgar.xml · nonDerivative · entry 2

Levy Lewis · CIK 0001726568 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,436

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 01, 2020 Filed Oct 5, 2020 20:02 UTC
Levy LewisChief Medical Officer
Exercise / conversionCommon Stock 1,395 $35.45 $49,452.75
Disclosure

SEC source: 0001179110-20-010218 · edgar.xml · nonDerivative · entry 1

Levy Lewis · CIK 0001726568 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,161

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 25, 2020 Filed Sep 29, 2020 20:01 UTC Exercise / conversionStock Option (right to buy) · Derivative 740 $0.00 Strike: $6.01 $0.00
Disclosure

SEC source: 0001179110-20-010004 · edgar.xml · derivative · entry 3

Frist William H. · CIK 0001477553 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,350

Underlying: Common Stock · 740 shares

Expires 2024-09-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vested as to 25% of the shares on September 10, 2015. The remainder of the shares vested in 36 equal monthly installments thereafter.

Read SEC document
September 25, 2020 Filed Sep 29, 2020 20:01 UTC SaleCommon Stock 740 $208.50 $154,290.00
Disclosure

SEC source: 0001179110-20-010004 · edgar.xml · nonDerivative · entry 2

Frist William H. · CIK 0001477553 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,418

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 6, 2020.

Read SEC document
September 25, 2020 Filed Sep 29, 2020 20:01 UTC Exercise / conversionCommon Stock 740 $6.01 $4,447.40
Disclosure

SEC source: 0001179110-20-010004 · edgar.xml · nonDerivative · entry 1

Frist William H. · CIK 0001477553 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,158

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 18, 2020 Filed Sep 22, 2020 20:22 UTC Exercise / conversionStock Option (right to buy) · Derivative 740 $0.00 Strike: $6.01 $0.00
Disclosure

SEC source: 0001179110-20-009907 · edgar.xml · derivative · entry 3

Frist William H. · CIK 0001477553 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,090

Underlying: Common Stock · 740 shares

Expires 2024-09-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vested as to 25% of the shares on September 10, 2015. The remainder of the shares vested in 36 equal monthly installments thereafter.

Read SEC document
September 18, 2020 Filed Sep 22, 2020 20:22 UTC SaleCommon Stock 740 $200.89 $148,658.60
Disclosure

SEC source: 0001179110-20-009907 · edgar.xml · nonDerivative · entry 2

Frist William H. · CIK 0001477553 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,418

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 6, 2020.

Read SEC document
September 18, 2020 Filed Sep 22, 2020 20:22 UTC Exercise / conversionCommon Stock 740 $6.01 $4,447.40
Disclosure

SEC source: 0001179110-20-009907 · edgar.xml · nonDerivative · entry 1

Frist William H. · CIK 0001477553 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,158

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 11, 2020 Filed Sep 15, 2020 20:09 UTC Exercise / conversionStock Option (right to buy) · Derivative 740 $0.00 Strike: $6.01 $0.00
Disclosure

SEC source: 0001179110-20-009766 · edgar.xml · derivative · entry 3

Frist William H. · CIK 0001477553 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,830

Underlying: Common Stock · 740 shares

Expires 2024-09-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vested as to 25% of the shares on September 10, 2015. The remainder of the shares vested in 36 equal monthly installments thereafter.

Read SEC document
September 11, 2020 Filed Sep 15, 2020 20:09 UTC SaleCommon Stock 740 $199.41 $147,563.40
Disclosure

SEC source: 0001179110-20-009766 · edgar.xml · nonDerivative · entry 2

Frist William H. · CIK 0001477553 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,418

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 6, 2020.

Read SEC document
September 11, 2020 Filed Sep 15, 2020 20:09 UTC Exercise / conversionCommon Stock 740 $6.01 $4,447.40
Disclosure

SEC source: 0001179110-20-009766 · edgar.xml · nonDerivative · entry 1

Frist William H. · CIK 0001477553 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,158

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 04, 2020 Filed Sep 8, 2020 20:19 UTC Exercise / conversionStock Option (right to buy) · Derivative 740 $0.00 Strike: $6.01 $0.00
Disclosure

SEC source: 0001179110-20-009621 · edgar.xml · derivative · entry 3

Frist William H. · CIK 0001477553 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,570

Underlying: Common Stock · 740 shares

Expires 2024-09-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vested as to 25% of the shares on September 10, 2015. The remainder of the shares vested in 36 equal monthly installments thereafter.

Read SEC document
September 04, 2020 Filed Sep 8, 2020 20:19 UTC SaleCommon Stock 740 $196.78 $145,617.20
Disclosure

SEC source: 0001179110-20-009621 · edgar.xml · nonDerivative · entry 2

Frist William H. · CIK 0001477553 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,418

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 6, 2020.

Read SEC document
September 04, 2020 Filed Sep 8, 2020 20:19 UTC Exercise / conversionCommon Stock 740 $6.01 $4,447.40
Disclosure

SEC source: 0001179110-20-009621 · edgar.xml · nonDerivative · entry 1

Frist William H. · CIK 0001477553 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,158

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 03, 2020 Filed Sep 4, 2020 16:01 UTC
Turitz AndrewSVP - Business Development
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 1,390 $0.00 Strike: $22.30 $0.00
Disclosure

SEC source: 0001179110-20-009580 · edgar.xml · derivative · entry 6

Turitz Andrew · CIK 0001726221 · SVP - Business Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,334

Underlying: Common Stock · 1,390 shares

Expires 2027-03-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vested as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter.

Read SEC document
September 03, 2020 Filed Sep 4, 2020 16:01 UTC
Turitz AndrewSVP - Business Development
SaleCommon Stock 1,390 $213.10 $296,209.00
Disclosure

SEC source: 0001179110-20-009580 · edgar.xml · nonDerivative · entry 4

Turitz Andrew · CIK 0001726221 · SVP - Business Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,015

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 3, 2020.

Read SEC document
September 03, 2020 Filed Sep 4, 2020 16:01 UTC
Turitz AndrewSVP - Business Development
Exercise / conversionCommon Stock 1,390 $22.30 $30,997.00
Disclosure

SEC source: 0001179110-20-009580 · edgar.xml · nonDerivative · entry 3

Turitz Andrew · CIK 0001726221 · SVP - Business Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,405

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 03, 2020 Filed Sep 8, 2020 20:18 UTC
Vandervoort Adam CChief Legal Officer, Secretary
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 1,165 $0.00 Strike: $38.55 $0.00
Disclosure

SEC source: 0001179110-20-009620 · edgar.xml · derivative · entry 5

Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,962

Underlying: Common Stock · 1,165 shares

Expires 2028-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option vested as to 25% of the shares on March 1, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter

Read SEC document
September 03, 2020 Filed Sep 8, 2020 20:18 UTC
Vandervoort Adam CChief Legal Officer, Secretary
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 1,447 $0.00 Strike: $22.30 $0.00
Disclosure

SEC source: 0001179110-20-009620 · edgar.xml · derivative · entry 4

Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,680

Underlying: Common Stock · 1,447 shares

Expires 2027-03-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vested as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter.

Read SEC document
September 03, 2020 Filed Sep 8, 2020 20:18 UTC
Vandervoort Adam CChief Legal Officer, Secretary
SaleCommon Stock 2,612 $213.10 $556,617.20
Disclosure

SEC source: 0001179110-20-009620 · edgar.xml · nonDerivative · entry 3

Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 16, 2020.

Read SEC document
September 03, 2020 Filed Sep 8, 2020 20:18 UTC
Vandervoort Adam CChief Legal Officer, Secretary
Exercise / conversionCommon Stock 1,165 $38.55 $44,910.75
Disclosure

SEC source: 0001179110-20-009620 · edgar.xml · nonDerivative · entry 2

Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,812

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 03, 2020 Filed Sep 8, 2020 20:18 UTC
Vandervoort Adam CChief Legal Officer, Secretary
Exercise / conversionCommon Stock 1,447 $22.30 $32,268.10
Disclosure

SEC source: 0001179110-20-009620 · edgar.xml · nonDerivative · entry 1

Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,647

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 02, 2020 Filed Sep 4, 2020 16:01 UTC
Turitz AndrewSVP - Business Development
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 717 $0.00 Strike: $38.55 $0.00
Disclosure

SEC source: 0001179110-20-009580 · edgar.xml · derivative · entry 5

Turitz Andrew · CIK 0001726221 · SVP - Business Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,900

Underlying: Common Stock · 717 shares

Expires 2028-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option vested as to 25% of the shares on March 1, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter.

Read SEC document
September 02, 2020 Filed Sep 4, 2020 16:01 UTC
Turitz AndrewSVP - Business Development
SaleCommon Stock 717 $227.80 $163,332.60
Disclosure

SEC source: 0001179110-20-009580 · edgar.xml · nonDerivative · entry 2

Turitz Andrew · CIK 0001726221 · SVP - Business Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,015

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 3, 2020.

Read SEC document
September 02, 2020 Filed Sep 4, 2020 16:01 UTC
Turitz AndrewSVP - Business Development
Exercise / conversionCommon Stock 717 $38.55 $27,640.35
Disclosure

SEC source: 0001179110-20-009580 · edgar.xml · nonDerivative · entry 1

Turitz Andrew · CIK 0001726221 · SVP - Business Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,732

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 01, 2020 Filed Sep 2, 2020 16:18 UTC
Verstraete StephanyChief Marketing Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 6,000 $0.00 Strike: $22.30 $0.00
Disclosure

SEC source: 0001179110-20-009488 · edgar.xml · derivative · entry 3

Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,600

Underlying: Common Stock · 6,000 shares

Expires 2027-03-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vested as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter.

Read SEC document
September 01, 2020 Filed Sep 2, 2020 16:18 UTC
Verstraete StephanyChief Marketing Officer
SaleCommon Stock 6,000 $219.34 $1,316,040.00
Disclosure

SEC source: 0001179110-20-009488 · edgar.xml · nonDerivative · entry 2

Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,276

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 4, 2020.

Read SEC document
September 01, 2020 Filed Sep 2, 2020 16:18 UTC
Verstraete StephanyChief Marketing Officer
Exercise / conversionCommon Stock 6,000 $22.30 $133,800.00
Disclosure

SEC source: 0001179110-20-009488 · edgar.xml · nonDerivative · entry 1

Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,276

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 01, 2020 Filed Sep 2, 2020 20:17 UTC
Levy LewisChief Medical Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 1,275 $0.00 Strike: $38.55 $0.00
Disclosure

SEC source: 0001179110-20-009487 · edgar.xml · derivative · entry 5

Levy Lewis · CIK 0001726568 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,714

Underlying: Common Stock · 1,275 shares

Expires 2028-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option vests as to 25% of the shares on March 1, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter.

Read SEC document
September 01, 2020 Filed Sep 2, 2020 20:17 UTC
Levy LewisChief Medical Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 1,395 $0.00 Strike: $35.45 $0.00
Disclosure

SEC source: 0001179110-20-009487 · edgar.xml · derivative · entry 4

Levy Lewis · CIK 0001726568 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,858

Underlying: Common Stock · 1,395 shares

Expires 2027-07-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vests as to 25% of the shares on July 14, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter.

Read SEC document
September 01, 2020 Filed Sep 2, 2020 20:17 UTC
Levy LewisChief Medical Officer
SaleCommon Stock 2,670 $219.34 $585,637.80
Disclosure

SEC source: 0001179110-20-009487 · edgar.xml · nonDerivative · entry 3

Levy Lewis · CIK 0001726568 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,766

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 13, 2020.

Read SEC document
September 01, 2020 Filed Sep 2, 2020 20:17 UTC
Levy LewisChief Medical Officer
Exercise / conversionCommon Stock 1,275 $38.55 $49,151.25
Disclosure

SEC source: 0001179110-20-009487 · edgar.xml · nonDerivative · entry 2

Levy Lewis · CIK 0001726568 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,436

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 01, 2020 Filed Sep 2, 2020 20:17 UTC
Levy LewisChief Medical Officer
Exercise / conversionCommon Stock 1,395 $35.45 $49,452.75
Disclosure

SEC source: 0001179110-20-009487 · edgar.xml · nonDerivative · entry 1

Levy Lewis · CIK 0001726568 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,161

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 01, 2020 Filed Sep 2, 2020 20:16 UTC
Bucaria MichelleChief Human Resources Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 764 $0.00 Strike: $37.75 $0.00
Disclosure

SEC source: 0001179110-20-009486 · edgar.xml · derivative · entry 2

Bucaria Michelle · CIK 0001732468 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,498

Underlying: Common Stock · 764 shares

Expires 2028-02-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The option vests as to 25% of the shares on February 20, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter.

Read SEC document
September 01, 2020 Filed Sep 2, 2020 20:16 UTC
Bucaria MichelleChief Human Resources Officer
Exercise / conversionCommon Stock 764 $37.75 $28,841.00
Disclosure

SEC source: 0001179110-20-009486 · edgar.xml · nonDerivative · entry 1

Bucaria Michelle · CIK 0001732468 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,232

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.